Literature DB >> 12914612

Atrial fibrillation in patients with congestive heart failure.

Bradley P Knight1.   

Abstract

CHF and AF are common problems that are frequently encountered together. These two disease states interact in a way that can result in a viscous cycle. This brief review will attempt to address the interaction between AF and CHF, atrial pathology and abnormal electrophysiology, clinical consequences, prognostic importance, and therapy.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12914612     DOI： 10.1046/j.1460-9592.2003.t01-1-00241.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN： 0147-8389            Impact factor:   1.976


  4 in total

1.  Determinants of a reduced heart rate variability in chronic atrial fibrillation.

Authors:  Maciej Sosnowski; Peter W Macfarlane; Michał Tendera
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-10       Impact factor: 1.468

2.  Genome-wide linkage scan identifies a novel genetic locus on chromosome 5p13 for neonatal atrial fibrillation associated with sudden death and variable cardiomyopathy.

Authors:  Carlos Oberti; Lejin Wang; Lin Li; Jiamei Dong; Shaoqi Rao; Wei Du; Qing Wang
Journal:  Circulation       Date:  2004-12-13       Impact factor: 29.690

3.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.

Authors:  Jonathan G Howlett; Robert S McKelvie; J Malcolm O Arnold; Jeannine Costigan; Paul Dorian; Anique Ducharme; Estrellita Estrella-Holder; Justin A Ezekowitz; Nadia Giannetti; Haissam Haddad; George A Heckman; Anthony M Herd; Debra Isaac; Philip Jong; Simon Kouz; Peter Liu; Elizabeth Mann; Gordon W Moe; Ross T Tsuyuki; Heather J Ross; Michel White
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

Review 4.  Electrophysiological remodeling in heart failure.

Authors:  Yanggan Wang; Joseph A Hill
Journal:  J Mol Cell Cardiol       Date:  2010-01-20       Impact factor: 5.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.